Kate’s Research Comment Archives - Beechnut Medical Rooms

Efficacy and tolerability of guanylate cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation

June 10, 2019

Authors: Shah ED et al. Summary: This was a systematic review and meta-analysis of eight trials investigating linaclotide and seven…

Kate’s Research Comment

Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease

June 3, 2019

beechnutmedical_@dm1.N

No Comments

Authors: Chaparro M et al. Summary: This article reported results from the retrospective multicentre European TEDDY study, in which 381…

Kate’s Research Comment

Corticosteroid sparing in inflammatory bowel disease is more often achieved in the immunomodulator and biological era

May 24, 2019

beechnutmedical_@dm1.N

No Comments

Authors: Jeuring SFG et al. Summary: Changes in corticosteroid use over time and the corticosteroid-sparing effects of immunomodulators and biologicals…

Kate’s Research Comment

Helicobacter pylori therapy for the prevention of metachronous gastric cancer

May 18, 2019

beechnutmedical_@dm1.N

No Comments

Authors: Choi IJ et al. Summary: Patients who had undergone endoscopic resection of early gastric cancer or high-grade adenoma were…